Technology | Telecardiology | July 19, 2016

Dictum Health Initiates Telehealth Study for Neonate Cardiology

Study will assess impact of Virtual Examination Room on outcomes, readmission rates for post-surgical neonate patients

Dictum Health, telehealth study, IDM100 tablet, neonate cardiology, in-home monitoring

July 19, 2016 — Dictum Health Inc. announced the launch of a post-U.S. Food and Drug Administration (FDA)-approval study of its end-to-end telehealth care-delivery system with University of California Davis Medical Center in Sacramento.

The study will demonstrate the effectiveness of Dictum Health’s end-to-end telehealth system, built upon its FDA-cleared, cyber-secure IDM100 integrated medical tablet. The tablet uses a HIPAA-compliant cloud and Care Central portal that enables a completely private Virtual Exam Room (VER) for in-home monitoring of high-risk infants. The neonatal cardiac care team will monitor the patients remotely and conduct examinations using VER. The goal is to improve clinical outcomes of children who have undergone surgery for single-ventricle hypoplastic left heart syndrome and are receiving post-surgical care at home.

Patients will use the VER to see a physician while simultaneously streaming real-time vital signs, cardiopulmonary data, medical images, analytics and trending information. Each of the 25 patients selected each year for the study will be assigned an IDM100 tablet upon hospital discharge for regular monitoring at home using live video and vital-signs management functions.

The study will evaluate how the VER’s live video streaming, vital-signs management and simultaneous real-time biometric data streaming through a secure, Web-enabled portal enhances home monitoring of at-risk infants. The study will also measure hospital readmission rates for these post-surgical patients and assess levels of acceptance of this technology by both providers and family caregivers.

For more information: www.dictumhealth.com

Related Content

Videos | Congenital Heart

Tom Jones, M.D., director, cardiac cath labs, Seattle Children’s Hospital, explains the importance of the heart team ...

Home September 15, 2021
Home
News | Congenital Heart

June 29, 2021 – Echocardiography with ultrasound enhancing agents (UEAs) has proven to be a valuable imaging procedure ...

Home June 29, 2021
Home
Videos | Congenital Heart

Tom Jones, M.D., director, cardiac catheterization laboratories, Seattle Children’s Hospital, explains some of the new ...

Home May 26, 2021
Home
News | Congenital Heart

May 1, 2021 - An analysis of a new international registry reveals benefits of using a longer covered stent for ...

Home May 01, 2021
Home
News | Congenital Heart

March 24, 2021 — Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. each year and is often ...

Home March 24, 2021
Home
News | Congenital Heart

February 16, 2021 – In recognition of World Congenital Heart Defects (CHD) Awareness week, HD Medical Inc. announced it ...

Home February 16, 2021
Home
News | Congenital Heart

August 10, 2020 - The Guerin Family Congenital Heart Program in the Smidt Heart Institute at Cedars-Sinai is expanding ...

Home August 10, 2020
Home
News | Congenital Heart

May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were ...

Home May 21, 2020
Home
News | Congenital Heart

May 4, 2020 – The Society for Cardiovascular Angiography and Interventions (SCAI) has released a position statement on ...

Home May 04, 2020
Home
News | Congenital Heart

October 24, 2019 — Investigators at the University of Arizona Steele Children's Research Center are leading a statewide ...

Home October 24, 2019
Home
Subscribe Now